Bastiaan Privé

Bastiaan Privé is a Researcher at the Department of Radiotherapy, Erasmus University Medical Center (Erasmus MC). His research focuses on advanced molecular imaging and radioligand therapy, particularly in prostate cancer and salivary gland malignancies. He specializes in the development and optimization of PSMA-targeted therapies using radiopharmaceuticals like lutetium-177 and fluorine-18.

Key research areas include dosimetry modeling for radiation therapy, genetic biomarker analysis (e.g., TP53 alterations), and comparative imaging studies (MRI/PET/CT). His work integrates clinical trials, pharmacological evaluations, and computational methods to improve diagnostic accuracy and treatment efficacy.

Recent studies highlight innovations in single-time-point dosimetry using Bayesian fitting, the impact of genetic profiles on therapy response, and the application of PSMA-1007 PET for prostate cancer recurrence detection. Collaborations span multidisciplinary teams involving oncologists, radiologists, and biomedical engineers.

Notable contributions include pioneering PSMA-based therapies for salivary gland cancers and advancing multimodal imaging protocols for early cancer detection. His research emphasizes translational applications with direct clinical relevance, supported by peer-reviewed publications in journals like Theranostics and Radiology.